84 related articles for article (PubMed ID: 32797261)
1. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
[TBL] [Abstract][Full Text] [Related]
2. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.
Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG
J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637
[TBL] [Abstract][Full Text] [Related]
3. Robot-assisted retroperitoneal lymph node dissection: Initial experience in Japan.
Takahara K; Motonaga T; Okumura J; Yamakawa S; Yagi K; Nakamura W; Saruta M; Nukaya T; Takenaka M; Zennami K; Ichino M; Sasaki H; Sumitomo M; Shiroki R
Asian J Endosc Surg; 2024 Jan; 17(1):e13262. PubMed ID: 37944943
[TBL] [Abstract][Full Text] [Related]
4. Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer.
Chavarriaga J; Atenafu EG; Mousa A; Langleben C; Anson-Cartwright L; Jewett M; Hamilton RJ
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38278693
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer.
D'Andrea V; Jason Qian Z; Yim K; Egan J; Magnani CJ; Feldman A; Salari K; Tewari A; Steele G; Mossanen M; Preston M; Chang SL; Clinton TN
Urol Oncol; 2023 Dec; 41(12):489.e1-489.e6. PubMed ID: 37980224
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.
Macleod LC; Rajanahally S; Nayak JG; Parent BA; Ramos JD; Schade GR; Holt SK; Dash A; Gore JL; Lin DW
Urology; 2016 May; 91():70-6. PubMed ID: 26802801
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract][Full Text] [Related]
8. Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic Dissection.
Roshan A; Shah B; Anderson KD; Murphy S; Thomas B; McPhee AS; Lamb BW; Durrani AJ; Patel AJK
Ann Surg Oncol; 2024 Apr; 31(4):2727-2736. PubMed ID: 38177461
[TBL] [Abstract][Full Text] [Related]
9. Robotic-assisted Pediatric Thoracic and Abdominal Tumor Resection: An Initial Multi-center Review.
Svetanoff WJ; Carter M; Diefenbach KA; Michalsky M; DaJusta D; Gong E; Lautz TB; Aldrink JH
J Pediatr Surg; 2024 Feb; ():. PubMed ID: 38490885
[TBL] [Abstract][Full Text] [Related]
10. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.
Małkiewicz B; Świrkosz G; Lewandowski W; Demska K; Szczepaniak Z; Karwacki J; Krajewski W; Szydełko T
Curr Oncol Rep; 2024 Apr; 26(4):318-335. PubMed ID: 38430323
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.
Yuan Y; Zhang D; Ning Y; Luo H; Qiu X; Tan Y; Li Y; Yang X
Front Oncol; 2023; 13():1257528. PubMed ID: 38169835
[TBL] [Abstract][Full Text] [Related]
12. The role of robotic retroperitoneal lymph node dissection in testicular cancer: a systematic review and meta-analysis.
Ge S; Zeng Z; Li Y; Gan L; Meng C; Li K; Wang Z; Zheng L
Int J Surg; 2023 Sep; 109(9):2808-2818. PubMed ID: 37222676
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the perioperative outcomes of laparoscopic and open retroperitoneal lymph node dissection for low-stage (stage I/II) testicular germ cell tumors: a systematic review and meta-analysis.
Ge S; Gan L; Meng C; Li K; Wang Z; Zeng Z; Zheng L; Li Y
Int J Surg; 2023 Apr; 109(4):995-1005. PubMed ID: 36917132
[TBL] [Abstract][Full Text] [Related]
14. Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience.
Nason GJ; Hamilton RJ
World J Urol; 2022 Feb; 40(2):335-342. PubMed ID: 34988650
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
[TBL] [Abstract][Full Text] [Related]
16. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
